INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases
INmune Bio expanded its collaboration with Anthony Nolan to secure a long-term supply of umbilical cord tissue for its CORDStrom platform. The amended agreement supports development in RDEB, oncology via CORDStrom-TRAIL, and inflammatory diseases like osteoarthritis and SLE.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.